SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF PEPTIDYL ALPHA-KETO HETEROCYCLES AS NOVEL INHIBITORS OF PROLYL ENDOPEPTIDASE

被引:71
作者
TSUTSUMI, S
OKONOGI, T
SHIBAHARA, S
OHUCHI, S
HATSUSHIBA, E
PATCHETT, AA
CHRISTENSEN, BG
机构
[1] MERCK & CO INC,MERCK SHARP & DOHME RES LABS,RAHWAY,NJ 07065
[2] MICROCIDE PHARMACEUT INC,MENLO PK,CA 94025
关键词
D O I
10.1021/jm00047a007
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The preparation and in vitro prolyl endopeptidase (PEP) inhibitory activity of a series of alpha-keto heterocyclic compounds is described. The design is based on the introduction of alpha-keto heterocycles at the C-terminal end of substrate-like peptides. Many of the compounds including those substituted with thiazole, benzothiazole, benzoxazole, imidazole, and pyridine groups exhibit IC50 potencies of PEP inhibition at nanomolar levels. Structure-activity studies of the C-terminal heterocyclic groups indicate the importance of an sp(2) nitrogen atom at a beta-position from the adjoining ketone carbonyl group. This heterocyclic nitrogen atom would provide a critical hydrogen-bond interaction with the histidine residue of the catalytic triad in PEP. Our inhibitors would extend the generality of the alpha-keto heterocycle design to another serine protease.
引用
收藏
页码:3492 / 3502
页数:11
相关论文
共 45 条
[1]   ALPHA-AMINOALDEHYDES - TRANSITION-STATE ANALOG INHIBITORS OF LEUCINE AMINOPEPTIDASE [J].
ANDERSSON, L ;
ISLEY, TC ;
WOLFENDEN, R .
BIOCHEMISTRY, 1982, 21 (17) :4177-4180
[2]  
ANDREWS PC, 1982, J BIOL CHEM, V257, P5861
[3]   ALPHA-DIKETONE AND ALPHA-KETO ESTER DERIVATIVES OF N-PROTECTED AMINO-ACIDS AND PEPTIDES AS NOVEL INHIBITORS OF CYSTEINE AND SERINE PROTEINASES [J].
ANGELASTRO, MR ;
MEHDI, S ;
BURKHART, JP ;
PEET, NP ;
BEY, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (01) :11-13
[4]   SYNTHESIS AND AMNESIA-REVERSAL ACTIVITY OF A SERIES OF 7-MEMBERED AND 5-MEMBERED 3-ACYLAMINO LACTAMS [J].
ANGELUCCI, L ;
CALVISI, P ;
CATINI, R ;
COSENTINO, U ;
COZZOLINO, R ;
DEWITT, P ;
GHIRARDI, O ;
GIANNESSI, F ;
GIULIANI, A ;
GUARALDI, D ;
MISITI, D ;
RAMACCI, MT ;
SCOLASTICO, C ;
TINTI, MO .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (11) :1511-1528
[5]   INACTIVATION OF CALPAIN BY PEPTIDYL FLUOROMETHYL KETONES [J].
ANGLIKER, H ;
ANAGLI, J ;
SHAW, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (02) :216-220
[6]   INVITRO AND INVIVO INHIBITION OF PROLYL ENDOPEPTIDASE [J].
ATACK, JR ;
SUMANCHAUHAN, N ;
DAWSON, G ;
KULAGOWSKI, JJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 205 (02) :157-163
[7]   EVALUATION OF INTRINSIC BINDING-ENERGY FROM A HYDROGEN-BONDING GROUP IN AN ENZYME-INHIBITOR [J].
BARTLETT, PA ;
MARLOWE, CK .
SCIENCE, 1987, 235 (4788) :569-571
[8]   CALCULATION OF THE RELATIVE CHANGE IN BINDING FREE-ENERGY OF A PROTEIN-INHIBITOR COMPLEX [J].
BASH, PA ;
SINGH, UC ;
BROWN, FK ;
LANGRIDGE, R ;
KOLLMAN, PA .
SCIENCE, 1987, 235 (4788) :574-576
[9]   A MAJOR METABOLITE OF ARGININE VASOPRESSIN IN THE BRAIN IS A HIGHLY POTENT NEUROPEPTIDE [J].
BURBACH, JPH ;
KOVACS, GL ;
DEWIED, D ;
VANNISPEN, JW ;
GREVEN, HM .
SCIENCE, 1983, 221 (4617) :1310-1312
[10]   CENTRAL TARGET FOR THE BEHAVIORAL-EFFECTS OF VASOPRESSIN NEUROPEPTIDES [J].
DEWIED, D ;
GAFFORI, O ;
VANREE, JM ;
DEJONG, W .
NATURE, 1984, 308 (5956) :276-278